跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 198 条关于
“GalNAc”
全部
198
临床试验
76
药物
54
机构
15
资讯
53
6个月前
Korro Bio Advances RNA Editing Platform with KRRO-121 Nomination and $85 Million Financing
9个月前
Tangram Therapeutics Advances Novel RNAi Therapy TGM-312 to Clinical Trials for MASH Treatment
10个月前
Korro Bio's RNA Editing Drug Shows Promise but Falls Short of Efficacy Targets in Alpha-1 Antitrypsin Deficiency Trial
10个月前
Wave Life Sciences Reports Dose-Dependent Activin E Reductions Up to 85% with WVE-007 in Obesity Trial
去年
Insitro and Lilly Partner to Develop AI-Discovered Metabolic Disease Drugs
6个月前
Tangram Therapeutics Initiates First-in-Human Trial of TGM-312 for MASH Treatment
去年
Prime Medicine Advances Gene Editing Program for Alpha-1 Antitrypsin Deficiency with 72% Correction Rate
去年
Rona Therapeutics Files IND for RN3161, Novel siRNA Targeting INHBE for Obesity Treatment
去年
Wave Life Sciences Advances Obesity and Cardiometabolic Programs with RNA Therapies
去年
Wave Life Sciences Achieves First Human RNA Editing, Advances Pipeline
第 1 页,共 6 页
上一页
下一页